Prognostic impact of elevated fatty acid ‐binding protein 1 in patients with heart failure
ConclusionSerum FABP1 levels are elevated in compensated HF patients, and the magnitude of elevation is independently associated with pulmonary hypertension, right atrial hypertension, and worse clinical outcomes. FABP1 may serve as a new potential biomarker for the assessment of hitherto unrecognized derangement of cardio ‐hepatic interaction in HF.
Source: ESC Heart Failure - Category: Cardiology Authors: Kazuki Kagami,
Hiroaki Sunaga,
Hidemi Sorimachi,
Tomonari Harada,
Kuniko Yoshida,
Toshimitsu Kato,
Koji Kurosawa,
Ryo Kawakami,
Norimichi Koitabashi,
Tatsuya Iso,
Takeshi Adachi,
Masahiko Kurabayashi,
Masaru Obokata Tags: Original Research Article Source Type: research
More News: Atrial Fibrillation | Cardiology | Heart | Heart Failure | Hypertension | Liver | Pulmonary Hypertension | Urology & Nephrology